Speakers and tracks are still being unveiled for the Venture Dallas 2023 Summit. Confirmed speakers include (clockwise from upper left): AT&T's Vikram Taneja, Beautybio Founder Jamie O'Banion, Bestow's Melbourne O'Banion, Dialexa/IBM's Scott Harper, investor and Nextdoor founder Nirav Tolia, Rosy Wellness' Lyndsey Harper, Topgolf's Artie Starrs, and PGA's Arjun Chowdri. [Courtesy photos]
VanTrust Real Estate, which has an office in Dallas, has announced a new division that is designed to match its real estate expertise and capital resources with both public and private sector clients in the life sciences, R&D, institutional, governmental, biotech, pharmaceutical and technology industries....
Left: LinedanceAI co-founder Mohamed Elwazer; Center illustration: leonello/iStock; Right: Lantern Pharma CEO Panna Sharma
Dallas-Fort Worth is well known for its tech expertise. Now it being recognized as the place where technology meets life science—a convergence that’s driving rapid growth in the biotech ecosystem. Leaders in the industry attribute this success to the unique convergence of the region’s exceptional tech talent pool and cutting-edge developments in life science....
Nanoscope Therapeutics Inc., a Dallas-based clinical-stage biotechnology company developing gene therapies for retinal degenerative diseases, has appointed Massoud Motamed, Ph.D., as vice president of quality.
Motamed brings nearly a decade of CGMP quality and compliance experience, including extensive experience in manufacturing and regulatory review of gene therapy products....
Paul Dorman, Chairman and CEO of DFB Pharmaceuticals, assembled a team of internal and external experts after launching NanOlogy in a partnership with CritiTech and US Biotest in 2015. [Source images: BioNTX, DI]
Fort Worth-based NanOlogy has completed the enrollment of 18 patients in a Phase 2a trial for its proprietary particle drug delivery with standard-of care therapy in nonoperable lung cancer patients.
Lung cancer is the most lethal form of cancer with the highest mortality rate, according to the biotech, which aims to improve the treatment of cancer with its tumor-directed technology....